StockDuty ← Dashboard Aug 19, 2026 06:41 PM ET
SignalCorporate

MODERNA SHARES CLIMB OVER 150% AS MRNA VACCINE WITH MERCK SUCCEEDS IN LARGE TRIAL FOR SKIN CANCER - MINT

MRNA vaccine with Merck succeeds in large skin cancer trial, driving shares up over 110%.

What changed
Why it matters
MRNA vaccine with Merck succeeds in large skin cancer trial, driving shares up over 110%.
Sources
mint
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →STRATEGY EXPANDS STRC PREFERRED STOCK BUYBACK PROGRAM; SHARES DOWN - SEEKINGALPHA →